Related Experiment Videos
Prevention of arterial disease in experimental renal hypertension
Abstract:
1. This study examined the effect of various antihypertensive agents on the development of polyarteritis nodosa lesions along the mesenteric artery system over a 10 week period after renal artery clipping in uninephrectomized rats (lKlC). 2. Of the agents, only hydralazine, enalapril and diltiazem significantly inhibited systolic blood pressure (SBP) rise over the 10 week period (P less than 0.001). 3. All agents except hydralazine reduced the severity of arteritic lesions compared with lKlC rats, but only with enalapril (P less than 0.001), nifedipine (P less than 0.001), diltiazem (P less than 0.005), propranolol (P less than 0.001) and reserpine (P less than 0.05) was this reduction statistically significant. 4. There was a positive correlation between the degree of arteritic change and SBP, but the correlation coefficient was neither high (r = 0.68) nor highly significant (P = 0.03, d.f. = 9). On examining the data, this was due on the one hand to nifedipine, propranolol and reserpine reducing the severity of lesions without significantly inhibiting SBP, and on the other to hydralazine reducing SBP without significantly affecting the extent of arteritic change. 5. These findings suggest that factors other than mere SBP alone are involved in the pathogenesis of these arteritic lesions.
Insights
Antihypertensive drugs like enalapril and diltiazem reduced polyarteritis nodosa lesions in rats. However, blood pressure control alone doesn't fully explain lesion development, suggesting other factors are involved.
Area of Science:
- Cardiovascular Research
- Nephrology
- Pharmacology
Background:
- Polyarteritis nodosa (PN) is a systemic vasculitis affecting medium-sized arteries.
- Hypertension is a common comorbidity and potential contributor to PN pathogenesis.
- Understanding the role of antihypertensive agents in PN is crucial for treatment strategies.
Purpose of the Study:
- To investigate the efficacy of various antihypertensive agents in mitigating polyarteritis nodosa lesions.
- To determine the relationship between blood pressure control and the development of arteritic lesions.
- To explore factors beyond systolic blood pressure influencing PN pathogenesis.
Main Methods:
- A rat model of polyarteritis nodosa was induced via renal artery clipping in uninephrectomized rats (lKlC).
- Rats were treated with different antihypertensive agents (hydralazine, enalapril, diltiazem, nifedipine, propranolol, reserpine) over 10 weeks.
- Systolic blood pressure (SBP) and the severity of mesenteric artery arteritic lesions were assessed.
Main Results:
- Hydralazine, enalapril, and diltiazem significantly inhibited the rise in systolic blood pressure (SBP).
- Enalapril, nifedipine, diltiazem, propranolol, and reserpine significantly reduced the severity of arteritic lesions.
- A positive correlation between SBP and arteritic change was observed, but it was not strongly significant (r=0.68, P=0.03).
- Some agents lowered SBP without reducing lesions (hydralazine), while others reduced lesions without significantly lowering SBP (nifedipine, propranolol, reserpine).
Conclusions:
- Antihypertensive therapy can modulate the severity of polyarteritis nodosa lesions.
- Systolic blood pressure reduction alone does not fully account for the protective effects observed.
- Pathogenesis of polyarteritis nodosa involves factors independent of blood pressure.
- Further research is needed to elucidate these additional contributing factors.